Skadden advised Vertex Pharmaceuticals Incorporated, while Fenwick & West advised Alpine in the transaction. Vertex Pharmaceuticals Incorporated and Alpine Immune Sciences, Inc. have entered into a definitive...
Vertex Pharmaceuticals’ Acquisition of Alpine Immune Sciences
Novartis’ Acquisition of MorphoSys
Skadden advised MorphoSys AG in the deal. MorphoSys AG has entered into a Business Combination Agreement with Novartis data42 AG and Novartis AG (hereinafter collectively referred...
Eli Lilly’s $1.4 Billion Acquisition of POINT Biopharma
Kirkland & Ellis LLP is acting as legal counsel to Lilly, while Skadden, Arps, Slate, Meagher & Flom LLP is acting as legal counsel to POINT...
Astellas’ Acquisition of Iveric Bio
J.P. Morgan Securities LLC, acting through its affiliate JPMorgan Securities Japan Co., Ltd., acted as exclusive financial advisor to Astellas and Jones Day as Astellas’ legal...
Pfizer’s Acquisition of Seagen
Wachtell, Lipton, Rosen & Katz is acting as Pfizer’s legal advisor. Sullivan & Cromwell is serving as Seagen’s Board of Directors legal advisor. Skadden is advising...
Vertex’s $320 Million Acquisition of ViaCyte
Skadden advised Vertex Pharmaceuticals Incorporated on the deal while Cooley represented ViaCyte. Vertex Pharmaceuticals Incorporated (“Vertex”) has entered into a definitive agreement under which Vertex will acquire...
Thoma Bravo’s $2.6 Billion Acquisition of Bottomline Technologies
Skadden, Arps, Slate, Meagher & Flom and Wilmer Cutler Pickering Hale and Dorr represented Bottomline, while Kirkland & Ellis represented Thoma Bravo in the transaction. Debevoise...
MorphoSys’ $1.7 Billion Acquisition of Constellation Pharmaceuticals
Wachtell, Lipton, Rosen & Katz and Willkie Farr & Gallagher advised Constellation on the deal. Goodwin Procter, Dechert and Maiwald acted as legal advisors to Royalty...